How NSAID and aspirin allergy labels affect medical care
Clinical Impact and Epidemiology of Nonsteroidal Anti-inflammatory Drug Allergies
Looks at how reported allergies to NSAIDs (like aspirin) change the medicines people are given and their health outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11308813 on NIH RePORTER |
What this research studies
If I have a reported NSAID allergy, the team will use medical records to see how that label changes pain and heart treatment, including opioid prescriptions after surgery and aspirin use during heart attacks. They will compare large groups of patients with and without NSAID allergy labels and track outcomes like ongoing opioid use, cardiovascular events, and allergic reactions. The project also aims to identify clinical signs or test results that predict who truly has an immune-mediated NSAID allergy versus non-allergic side effects. The work combines electronic health record analysis with clinical allergy methods to clarify who needs to avoid NSAIDs.
Who could benefit from this research
Good fit: People with a documented or reported NSAID or aspirin allergy — especially those undergoing common surgeries or treated for acute coronary syndrome — are the primary candidates for this work.
Not a fit: People without any history of NSAID-related reactions or those not treated within the health systems analyzed may not directly benefit from this study.
Why it matters
Potential benefit: This could help more patients safely use effective NSAIDs and aspirin by removing incorrect allergy labels and avoiding unnecessary alternative drugs and their harms.
How similar studies have performed: Earlier de-labeling programs and smaller studies show many reported NSAID allergies are not true immune allergies and that clarifying labels can safely increase appropriate NSAID use, but large-scale outcome data are still limited.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Li, Lily — University of Washington
- Study coordinator: Li, Lily
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.